SMBG is indicated for self-management and pharmacological adjustments, especially in patients under insulin treatment, while CGM plays an important role in both prevention of hypoglycemia and therapy's effectiveness and safety in patients with type 1 diabetes or in selected cases of insulin-treated type 2 diabetes 35. Here, INS is linked to Hypoglycemia.